These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36166004)

  • 21. Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis.
    Chen H; Guo Y; Sun J; Dong J; Bao Q; Zhang X; Fu F
    J Immunol Res; 2020; 2020():2328675. PubMed ID: 32322592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
    Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
    Qiu H; Gao S; Sun Z; Wang J
    APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
    Banu N; Riera-Leal A; Haramati J; Ortiz-Lazareno PC; Panikar SS; Bastidas-Ramirez BE; Gutierrez-Silerio GY; Solorzano-Ibarra F; Tellez-Bañuelos MC; Gutierrez-Franco J; Bueno-Topete MR; Pereira-Suarez AL; Del Toro-Arreola S
    BMC Cancer; 2020 Nov; 20(1):1083. PubMed ID: 33172426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of B7-H6 in human glioma tissues promotes tumor progression.
    Jiang T; Wu W; Zhang H; Zhang X; Zhang D; Wang Q; Huang L; Wang Y; Hang C
    Oncotarget; 2017 Jun; 8(23):37435-37447. PubMed ID: 28415577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-H6 expression in non-small cell lung cancers.
    Zhang X; Zhang G; Qin Y; Bai R; Huang J
    Int J Clin Exp Pathol; 2014; 7(10):6936-42. PubMed ID: 25400778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological role and underlying mechanisms of B7-H6 in tumorigenesis.
    Hu Y; Zeng T; Xiao Z; Hu Q; Li Y; Tan X; Yue H; Wang W; Tan H; Zou J
    Clin Chim Acta; 2020 Mar; 502():191-198. PubMed ID: 31904350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer.
    Gutierrez-Silerio GY; Franco-Topete RA; Haramati J; Navarrete-Medina EM; Gutierrez-Franco J; Bueno-Topete MR; Bastidas-Ramirez BE; Ramos-Marquez ME; Del Toro-Arreola S
    BMC Immunol; 2020 Mar; 21(1):9. PubMed ID: 32138659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody.
    Li H; Huang C; Zhang Z; Feng Y; Wang Z; Tang X; Zhong K; Hu Y; Guo G; Zhou L; Guo W; Xu J; Yang H; Tong A
    Front Oncol; 2020; 10():1527. PubMed ID: 32984002
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Liu X; Guo R; Xu Y
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
    [No Abstract]   [Full Text] [Related]  

  • 32. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
    Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
    PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
    Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
    Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review].
    Wu FF; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):295-8. PubMed ID: 26913440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.
    Matta J; Baratin M; Chiche L; Forel JM; Cognet C; Thomas G; Farnarier C; Piperoglou C; Papazian L; Chaussabel D; Ugolini S; Vély F; Vivier E
    Blood; 2013 Jul; 122(3):394-404. PubMed ID: 23687088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.
    Brandt CS; Baratin M; Yi EC; Kennedy J; Gao Z; Fox B; Haldeman B; Ostrander CD; Kaifu T; Chabannon C; Moretta A; West R; Xu W; Vivier E; Levin SD
    J Exp Med; 2009 Jul; 206(7):1495-503. PubMed ID: 19528259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.
    Huang C; Li H; Feng Y; Li X; Zhang Z; Jiang C; Wang J; Yang C; Fu Y; Mu M; Zhao S; Wang Z; Kuang Y; Hou H; Wang Y; Guo W; Xu J; Yang H; Zhou L; Tong A; Guo G
    Theranostics; 2020; 10(23):10498-10512. PubMed ID: 32929362
    [No Abstract]   [Full Text] [Related]  

  • 38. The prognostic value of B7-H6 in esophageal squamous cell carcinoma.
    Zhou H; Dong J; Guo L; Wang X; Wang K; Cai X; Yang S
    Sci Rep; 2019 Dec; 9(1):18122. PubMed ID: 31792298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction.
    Müller T; Schlahsa L; Zhang HJ; Skaik Y; Eiz-Vesper B; Immenschuh S; Blasczyk R; Figueiredo C
    J Biol Regul Homeost Agents; 2014; 28(2):183-93. PubMed ID: 25001651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.
    Li Y; Wang Q; Mariuzza RA
    J Exp Med; 2011 Apr; 208(4):703-14. PubMed ID: 21422170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.